title: Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
abstract: OBJECTIVE
  The aim of the present study was to clinically and radiographically evaluate Mineral Trioxide Aggregate (MTA) as an agent for pulpotomy in primary teeth and to compare it with that of Formocresol (FC) pulpotomy.
  
  
  METHODS
  Seventy first and second primary mandibular molars of children were chosen on patients who required minimum two pulpotomies in either arch or same arch. After the standardized technique of Pulpotomy with MTA and Formocresol, all molars were treated with a thick mix of Zinc oxide Eugenol cement into the coronal pulp chamber followed by preformed stainless steel crown. The children were followed up for clinical and radio graphical examination after 6, 12 and 24 month for Pain, Swelling, Sinus/fistula, Periapical changes, Furcation radiolucency and internal resorption.
  
  
  RESULTS
  MTA represents 97% clinical success rate in comparison to Formocresol with 85% success. Radiographically also MTA showed more promising results with 88.6% success in comparison to Formocresol with 54.3%.
  
  
  CONCLUSIONS
  Thus, MTA pulpotomy has emerged as an easier line of treatment to save the premature loss of primary teeth due to caries or trauma.
authors.affiliation: Department of Pedodontics, Modem Dental College and Research Centre, Indore, India. priyankairen@gmail.com
authors.forename: Priyanka
authors.initials: P
authors.lastname: Airen
authors.forename: Anand
authors.initials: A
authors.lastname: Shigli
authors.forename: Bhuvnesh
authors.initials: B
authors.lastname: Airen
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D002648:Child; D003442:Crowns; D019140:Dental Care for Children / Q000379:methods; D003731:Dental Caries / Q000601:surgery; D004338:Drug Combinations; D005500:Follow-Up Studies; D005566:Formocresols / Q000627:therapeutic use*; D006801:Humans; D008963:Molar / Q000000981:diagnostic imaging / Q000601:surgery*; D010087:Oxides / Q000627:therapeutic use*; D011183:Postoperative Complications; D057872:Pulp Capping and Pulpectomy Agents / Q000627:therapeutic use*; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012387:Root Canal Filling Materials / Q000627:therapeutic use; D012391:Root Resorption / Q000000981:diagnostic imaging; D017640:Silicates / Q000627:therapeutic use*; D014094:Tooth, Deciduous / Q000000981:diagnostic imaging / Q000601:surgery*; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D005566:Formocresols; D010087:Oxides; D057872:Pulp Capping and Pulpectomy Agents; D012387:Root Canal Filling Materials; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C086631:mineral trioxide aggregate; C031025:formocresol